[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Diadexus Inc (DDXS)

Diadexus Inc (DDXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Diadexus Inc 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080

www.diadexus.com P: 650-246-6400

Sector:

Medical

INDUSTRY GROUPING:

Medical Products

Description:

DiaDexus, Inc. operates as a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease. The Company's patented product PLAC Test for Lp-PLA2, identifies hidden risk for heart attack and stroke. The PLAC Test is the only blood test cleared by the FDA to assess risk for coronary heart disease and ischemic stroke associated with atherosclerosis. DiaDexus, Inc. is headquartered in San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 80
Shares Outstanding, K 4,100
% of Insider Shareholders 4.42%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 18,110 K
Annual Net Income, $ -7,170 K
Last Quarter Sales, $ 3,530 K
Last Quarter Net Income, $ -1,690 K

Growth:

1-Year Return -99.71%
3-Year Return -99.89%
5-Year Return -99.72%
5-Year Revenue Growth 54.13%
5-Year Earnings Growth -51.20%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/11/16
Earnings Per Share ttm -1.99
EPS Growth vs. Prev Qtr -10.81%
EPS Growth vs. Prev Year -36.74%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 07/01/15

DDXS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -55.48%
Profit Margin % -39.59%
Debt/Equity 0.00
Price/Sales 0.00
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.53
Interest Coverage 0.00
60-Month Beta 0.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.